PENIMIXCINA 500 [iU]/g
BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE · OINTMENT · OPMX LLC
PENIMIXCINA is a ointment containing bacitracin, neomycin sulfate, polymixin b sulfate, pramoxine hydrochloride at 500 [iU]/g, taken topical. Manufactured by OPMX LLC.
Key Facts
- Brand Name
- PENIMIXCINA
- Generic Name
- BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE
- NDC Code (Product)
69729-615- Manufacturer
- OPMX LLC
- Strength
- 500 [iU]/g
- Dosage Form
- OINTMENT
- Route
- TOPICAL
- Marketing Status
- Application #
- M004
- Marketing Start
- 09/05/2018
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
USES FIRST AID TO HELP PREVENT INFECTION IN MINOR CUTS SCRAPES BURNS
Dosage & Administration
DIRECTIONS CLEAN THE AFFECTED AREA APPLY A SMALL AMOUNT OF THIS PRODUCT (AN AMOUNT EQUAL TO THE SURFACE AREA OF THE TIP OF A FINGER) ON THE AREA 1 TO 3 TIMES DAILY MAY BE COVERED WITH A STERILE BANDAGE
Warnings
WARNINGS For external use only. DO NOT USE IN THE EYES IF YOU ARE ALLERGIC TO ANY OF THE INGREDIENTS OVER LARGE AREAS OF THE BODY LONGER THAN 1 WEEK UNLESS DIRECTED BY A DOCTOR ASK A DOCTOR BEFORE USE IN CASE OF DEEP OR PUNCTURE WOUNDS ANIMAL BITES OR SERIOUS BURNS
Frequently Asked Questions
What is PENIMIXCINA used for?
PENIMIXCINA contains BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE. It is a ointment taken topical. Consult your doctor for specific uses.
Is PENIMIXCINA a controlled substance?
PENIMIXCINA is not classified as a controlled substance by the DEA.
What is the generic name for PENIMIXCINA?
The generic name for PENIMIXCINA is BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE. There are no other listed brand versions of BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE.
What is the NDC code for PENIMIXCINA 500 [iU]/g?
The NDC (National Drug Code) for PENIMIXCINA 500 [iU]/g is 69729-615, listed by OPMX LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)